Background Induced sputum potentially allows monitoring of airway inflammation in patients with asthma in a non-invasive way. However, the relationship between the cellular content in sputum and airway tissue has not been fully clarified.
Introduction
Department of Pulmonology, Leiden University Medical Centre, PO Box rr.ii -r -i . 1.1 ri--9600, NL-23OORC Leiden, The Netherlands. ^^e charactenstic feature m the pathology of asthma is Supported by a grant from the Commission of the European Communities airway inflammation [1] , which has extensively been inves-(ECSC grant 7280-03-056).
tigated in bronchial biopsies and bronchoalveolar lavage (BAL). Bronchoscopy, however, is an invasive procedure, and is not easily applicable in large scale diagnostic and follow-up studies. Analysis of sputum might be an alternative, non-invasive method to obtain airway secretions, which can potentially be used to monitor airway inflammation in asthma. Studies of bronchial biopsies from asthmatic subjects have demonstrated increased infiltration of macrophages, T lymphocytes, eosinophils and mast cells into the lamina propria when compared with healthy subjects [2] [3] [4] [5] . In addition, increased numbers of activated lymphocytes and eosinophils have been found in the lamina propria [6] . The inflammatory state of the airways in biopsies and BAL appears to be dependent on the treatment level of the disease. In asthmatics using inhaled steroids fewer T lymphocytes, eosinophils, and mast cells have been found in bronchial biopsy specimens as compared with asthmatics using inhaled short-acting |S2-agonists only [4] . And even though treatment of asthmatic subjects with inhaled steroids does not affect cell differentials in BAL [7, 8] , it does reduce the absolute number of recovered eosinophils and the expression of the T lymphocyte activation markers CD25 and HLA-DR in BAL [8] .
Similar changes have been observed in the cellular content of sputum, either spontaneously expectorated or induced by inhalation of hypertonic saline aerosols, in asthma. Induced sputum from asthmatics is characterized by an increased percentage of eosinophils and mast cells, and by a decreased percentage of macrophages when compared to healthy subjects [9] [10] [11] . Exacerbations seem to be associated with even higher percentages of eosinophils in some, but not all patients, together with an increase in mast cells and a decrease in the percentages of macrophages in induced sputum [12, 13] . These findings have been extended by using intervention studies. Fahy et al. have shown that eosinophils and neutrophils are elevated in induced sputum 24 h after allergen challenge [14] , whereas treatment of asthmatic subjects with oral corticosteroids decreased the percentage of eosinophils [15] .
At present, it is unknown whether cellular inflammation in induced sputum is fully representative for the ongoing inflammatory process in airway tissue. The first studies on the comparison between the cellular content of sputum with that in bronchial wash (BW) and BAL in patients with asthma show variable correlations in eosinophil numbers between induced sputum and BW [16] [17] [18] , and between induced sputum and BAL [18] [19] [20] . One of the studies also showed a correlation between induced sputum and BW or BAL for neutrophils [18] . With regard to the relationship between induced sputum and bronchial biopsies, it has recently been reported that there is a trend towards a correlation between the two materials for eosinophil counts only [20] .
The aim of this study was to further examine whether there is a relationship between inflammatory cell counts in hypertonic saline-induced sputum on the one hand, and those in BW, BAL and bronchial biopsies on the other, in a relatively large group of asthmatic subjects. To that end, we have conducted a study in clinically stable atopic asthmatic subjects, covering a wide range in lung function and airway hyperresponsiveness. In these patients, we compared the inflammatory cell counts between sputum induced by inhalation of hypertonic saline, and BW, BAL and bronchial biopsies as obtained by fibreoptic bronchoscopy.
Methods

Subjects
Eighteen non-smoking, atopic asthmatic subjects participated in this study. Ten subjects (seven male and three female, 18-44 years) used inhaled short-acting /32-agonists on demand only, and eight subjects (four male and four female, 19-50 years) were treated with regular inhaled corticosteroids and inhaled short-and/or long-acting 182-agonists on demand. All subjects had an FEV] >60% predicted [21] , which was reversible in all subjects by >12% predicted [21] or by reaching the normal range (>80% pred) after administration of 400 /xg salbutamol per metered dose inhaler (MDI) connected to an aerosol chamber. All subjects were hyperresponsive to inhaled methacholine as shown by a provocative concentration to cause a 20% fall in FEVi (PC20FEV1) of 8 mg/mL or less [22] . Atopy was indicated by a positive skin-prick test (>3 mm weal) to one or more common airbome allergen extracts (Soluprick, ALK, Denmark). They were clinically stable without a recent history of an upper respiratory tract infection. During the study, FEV| had to be stable (within 10% range of predicted value). The subject characteristics are shown in Table 1 . The study was approved by the Medical Ethics Committee at the Leiden University Medical Centre, The Netherlands.
Design
All subjects attended the laboratory on four occasions. At the first visit, clinical characteristics were documented by a questionnaire, and a skin-prick test and spirometry were carried out. Bronchial hyperresponsiveness to methacholine was measured approximately 14 days later (second visit). On visit 3 (at least 48 h later) and visit 4 (within 4-12 days) either sputum was induced or fibreoptic bronchoscopy was performed. The sequence of these procedures was randomized in order to preclude any bias due to potential carryover effects. Immediately prior to bronchoscopy, reversibility of lung function to 400/^g of inhaled salbutamol was tested. Short-acting bronchodilators were withheld for at least 8 h, and long-acting bronchodilators were withheld for 24 h before each procedure, whilst the prescribed doses of inhaled corticosteroids were continued.
Spirometry
Flow-volume curves were recorded using a dry rolling seal spirometer (Morgan Spiroflow, UK) and displayed on a XYrecorder (Kipp, The Netherlands) with a timing device to provide a spike to determine FEVj, Maximal flow-volume curves were performed according to European standards [21] ,
Inhalation challenge test
Methacholine provocation tests were performed according to the standardized 2min tidal breathing method [22] , The response to methacholine was measured by FEV, at 90s after inhalation of each dose. The provocative concentration causing 20% fall in FEV, (PC20FEV1) was calculated by linear interpolation of the last two points of the log concentration-response curves, Salbutamol (200/tg) was administered by MDI connected to an aerosol chamber, after completion of the challenges.
Sputum induction
Sputum was induced by inhalation of hypertonic (4.5%) saline aerosols [23] . Sodium chloride aerosols were generated at room temperature by a DeVilbiss Ultraneb 99 ultrasonic nebulizer at maximal output setting (2.5 mL/ min). The generated aerosols of this nebulizer have a particle size with a mass median aerodynamic diameter of 4.5 ^m [24] , The aerosols were administered to the subject through a 100 cm long tube with an internal diameter of 22 mm, and inhaled by the mouth through a two-way valve box (no,2700; Hans Rudolph, Kansas City, MO, USA) with the nose clipped. Immediately before inhalation of the aerosols, baseline FEV] was recorded, and 200/xg salbutamol were administered per MDI connected to an aerosol chamber, for safety reasons. The subjects then inhaled hypertonic saline aerosols in periods of 5 min up to a maximum of 50 min or until enough sputum was obtained (approximately 5 g). Every 5 min, subjects were asked to rinse their mouth and throat with water and to expectorate sputum into a clean plastic container by coughing. FEV i was monitored directly before and after sputum induction, and whenever the subject felt uncomfortable. When FEVi fell by more than 20% from baseline during or after sputum induction, a final dose of 200 fx,g salbutamol was administered.
Sputum processing
Sputum samples were processed according to the method of Fahy et al. [11, 23] . Differential cell counts of leucocytes, cylindric epithelial cells and squamous cells were performed by a qualified cytologist on coded, May-Grlinwald-Giemsa stained cytospins. A sputum sample was considered adequate when the percentage of squamous cells was lower than 80%. To correct for the variable salivary contamination, differential leucocyte and cylindric epithelial cell counts were expressed as percentages of 500 nucleated cells excluding squamous cells. Cell differentials of metachromatic cells (mast cells and basophils) were made by counting 5000 nucleated cells on slides stained with 1 % toluidine blue (w/v) in methanol/aqua dest (v/v: 30/70, pH6.6). Metachromatic cells were expressed as the number of positively stained cells per 1000 (non-squamous) cells. Furthermore, absolute cell numbers per mL sputum were calculated by multiplying the cell percentage with the total (nonsquamous) cell number in sputum, divided by the volume of the sputum sample.
Processing of biopsies and cell quantification
The biopsies were embedded in OCT medium (Miles Inc. Diagnostics Division, Elkhart USA), and snap-frozen in isopentane cooled by iced CO2 [27] . Samples were stored at -70 °C pending further processing. Six /xm sections were air-dried for 1 h, and fixed in a mixture of equal parts acetone:methanol for 2 min. Immunohistochemical staining was performed using an indirect immunoperoxidase technique with the following monoclonal antibodies against: eosinophil cationic protein (EGl), secreted form of eosinophil cationic protein (EG2) (both Pharmacia, Sweden), mast cell tryptase (AAl, kindly donated by Dr R. Djukanovic, Southampton University Hospital, Southampton, UK), neutrophil elastase (Dako, The Netherlands), CD45 (CLA), CD3 (UCHT-1), CD4 (leu 3a) and CD8 (leu 2a) (all Becton Dickinson, Mountain View, CA, USA). Phosphate buffered saline was used as a negative control of immunostaining.
For each antibody and each localization, the number of positively stained cells were counted in a 115 ^m deep, randomly selected zone along the length of the epithelial basement membrane by means of a Video Interactive Display Analysis System (VIDAS II, Kontron Electronik GmbH, Munich, Germany) [6, 27] . Slides were coded and counted twice by one observer in a blinded fashion. Light microscopy analysis was performed using a Zeiss microscope at a magnification of x200. The mean number of positive cells/ mm'^ lamina propria, calculated on pooled data of the three localizations, is presented. Counted areas covered at least Bronchoscopy Fibreoptic bronchoscopy and BAL were carried out according to a standardized protocol based on recent recommendations [25] [26] [27] , and was performed using a Pentax bronchoscope (outer diameter 6 mm; Pentax Optical Co., Japan) [27] . The bronchoscope was introduced through the nose or mouth with the patient in supine position and wedged into a subsegmental bronchus of the lingula. Lavage was performed with three 50 mL aliquots of physiological saline pre-warmed to 37 °C. Each aliquot was immediately recovered using a negative pressure <20 mmHg. The first recovered tube of fluid (maximal 20 mL) was considered as BW. After completion of lavage, a total of three mucosal biopsies were taken from the main carina, the middle lobe carina and a segmental carina of the right lower lobe using cup forceps (Olympus FB-21C, Tokyo, Japan). Throughout the procedure 100% oxygen was delivered via a nasal cannula at a rate of 4 L/min whilst HbO2 saturation was monitored continuously using an oximeter (N-180, Nellcor, Hay ward, CA, USA) with the probe placed on a finger.
Processing of lavage fluid
After recovery of the lavage, fluids were kept on ice pending further processing. BW and BAL fluids were filtrated and centrifugated at 1500r.p.m. (4°C) for 10 min. The supernatant was aspirated and stored at -20°C for later analysis. The cell pellet was resuspended in PBS/BSA 1% (pH7.8). The cell suspension was used for determination of the cell concentration using a haemacytometer (Tamson, Zoetermeer. The Netherlands), cytospin preparation (Nordic cytocentrifuge, Tilburg, The Netherlands) and determination of cell markers by flow cytometry.
Differential cell counts of BW and BAL of both inflammatory and metachromatic cells were performed in the same way as in sputum. However, squamous epithelial cells were not counted since the percentage of these cells in lavage fluid was negligible.
Cell preparation for flow cytometry
For detection of the different T lymphocyte subpopulations (CD3, CD4 and CD8 positive cells) both sputum and BAL were analysed by flow cytometry. Monoclonal antibodies labelled with fluorescein (FITC), phycoerythrin (PE) or peridinin-chlorophyll-protein-conjugate (PerCP) (all obtained from Becton Dickinson, USA) were used to study the following combinations of determinants: CD45 (FITC) and CD 14 (PE) (positive control to set the lymphocyte gate), cells only (control for determination of autofluorescence) and CD4 (FITC) and CD8 (PE). In addition, mouse IgGl (FITC) and IgG2 (PE) were used as a control for aspecific binding. As a third fluorescent parameter, CD3 (PerCP) was used in sputum samples and LDS-751 in methanol containing 1% paraformaldehyde in BAL samples, CD3 (PerCP) was added to the cell suspensions at the same time as the previously mentioned combinations of monoclonal antibodies.
In order to be able to set lymphocyte gates, heparinized blood was used. As a control for sputum, blood of each individual subject was lysed with NH4CI for 20 min on ice, centrifugated (10 min 1500r,p.m.), the pellet resuspended in lysis buffer and centrifugated again, followed by sputolysin treatment as sputum. As control for BAL, lymphocytes were isolated from blood with a standard ficoU procedure.
A maximum of 0,5 x 10^ cells in PBS/BSA 1% (pH7.8) were incubated with saturating concentrations of the above mentioned combinations of monoclonal antibodies (to a final volume of 100 fiL) for 30 min in the dark. All steps were performed at 4°C. Suspensions were washed with 4mL of PBS/BSA 1% (pH7.4) (lOmin 1500r,p.m,), The cell pellet of sputum and control blood samples were then resuspended in 0,5 mL PBS/BSA 1% (pH7.8), and the cell pellet of BAL and control blood samples in 0,5 mL methanol containing LDS-751 and 1% paraformaldehyde and incubated 30 min at 4°C in the dark. Cell suspensions were stored in the dark at 4°C pending flow cytometric analysis,
Elow cytometry
Flow cytometric analyses of the labelled sputum, BAL and peripheral blood (lymphocyte) samples were performed on a FACScan (Becton Dickinson, USA), Subsequent generation of graphics and analysis of lymphocyte subsets were performed on a Hewlett-Packard 340 computer.
For each combination of monoclonal antibodies, 10000 cells of BAL and blood, and 50 000 cells of sputum were analysed. Both for sputum and BAL, a gate on lymphocytes and a gate on CD3''' cells were combined in order to be able to analyse lymphocytes. Gates were set on blood samples and the same gate specifications were used for sputum or BAL, CD3 expression within these gates was used for determination of CD4 and CD8 positive lymphocytes. Results of the analyses for BAL are presented as percentages of vital lymphocytes within the gated lymphocyte compartment.
Since CD3 positive lymphocytes in sputum were more spread over the forward/sideward scatter plot than in BAL, CD4 and CD8 positive lymphocytes were expressed as percentages of the number of gated CD3 positive lymphocytes. CD4 and CD8 percentages in sputum and BAL were corrected for non-specific antibody binding. T lymphocyte subsets were also evaluated by calculating their CD4/CD8 ratio.
Statistics
Before analysis, PC20 values for methacholine were logarithmically transformed. Since the cell counts in bronchial biopsies were not statistically different between the three localizations (ANOVA P>O.O6), cell counts from the three biopsy localizations were pooled and the mean was calculated. Part of the cell counts showed a skewed distribution while the rest of the data were normally distributed. Therefore, all data on cell counts are presented as median (range). For presentation in figures, eosinophil percentages and numbers were logarithmically transformed because of nonnormal distribution. However, since eosinophil counts included some zero values, one was added to all values before logtransfonnation, Between-group differences were detected using the non-parametric Mann-Whitney t/-test. Non-parametric statistical tests were employed to test for any correlation (Spearman's rank correlation coefficient, Rs). Differential sputum cell counts (expressed as percentage non-squamous cells) were used in the comparison with differential cell counts in BW and BAL, while absolute cell numbers in sputum (expressed as cells per mL) were used in the comparison of inflammatory cell counts between induced sputum and bronchial biopsies, A probability value of less than 0.05 was considered significant. All analyses were performed using the Statistical Package of the Social Sciences (SPSS-PC -t-).
Results
All subjects completed the study. Sputum was induced successfully in all subjects. All sputum samples could be analysed for differential cell counts since the highest percentage of squamous epithelial cells was 69.7. In one subject (No. 18) total cell count was not noted and absolute cell counts could therefore not be calculated. Bronchoscopy was well tolerated by all the subjects. In one subject (No. 6), the BW was contaminated with erythrocytes and this sample was not included in the analysis. Flow cytometric data of sputum were not obtained in three cases (No. 9, 10 and 18) because their sputum did not contain enough cells to allow analysis with flow cytometry.
Differential cell counts in induced sputum, BW and BAL are shown in Table 2 , absolute cell counts in sputum in Table 3 , flow cytometric data in Table 4 and cell counts in bronchial biopsies in Table 5 . The subjects using 182-agonists only and steroid-using subjects were pooled in the analysis, because they were not significantly different with respect to age, FEVj, PC20FEV, to methacholine, and reversibility in FEVj following salbutamol. Furthermore, no significant differences were found between the two subgroups concerning differential cell counts in sputum, BW and BAL, except for CD8 positive lymphocytes in BAL, as determined by flow cytometry. BAL fiuid from subjects using 182-agonists only contained less CDS"*" lymphocytes as compared with subjects on inhaled steroids {P = 0.045). Considering the absolute cell counts in sputum, induced sputum from subjects using /32-agonists only contained more macrophages/mL sputum, as compared with induced sputum from subjects on inhaled steroids (P = 0.04). In bronchial biopsies there was a significant difference between the two subgroups in the number of mast cells (P = 0.04), with higher numbers of mast cells in subjects using j32-agonists only.
Sputum vs bronchial wash
For eosinophils there was a significant correlation between their percentage in sputum and in B W (R^ = 0.52, P = 0.03) (Fig. la) . Furthermore, there was a trend towards such a correlation for lymphocytes (i?s = 0.46, P = 0.07). There were no correlations between induced sputum and bronchial wash for neutrophils, macrophages or cylindric epithelial cells percentages.
Sputum vs bronchoalveolar lavage
There was a significant correlation for the percentage of eosinophils between sputum and BAL {R^ = 0.55, P = 0.02) (Fig. lb) . Furthermore, CD4+ lymphocytes, as determined by flow cytometry, correlated positively between induced sputum and BAL {R^ = 0.55, P = 0.03) (Fig. 2) . In addition, there was a trend towards a correlation between sputum and BAL for CD8+ lymphocytes (/?s = 0.48, P = 0.08) and for the CD4/CD8 ratio {R^-Q.Al, /' = 0.09). The percentage neutrophils, macrophages or cylindric epithelial cells in sputum did not correlate with those in BAL.
Sputum vs bronchial biopsies
There was a trend towards a correlation between the number of eosinophils/mL sputum and the number of EG2"'' eosinophils/mm^ lamina propria in bronchial biopsies {R^ = 0.44, P = 0.07) (Fig. lc) . Lymphocyte, neutrophil and mast cell numbers in induced sputum did not correlate with cell numbers in broncbial biopsies. 
Discussion
Tbis study bas sbown tbat for tbe percentage of eosinopbils tbere is a correlation between bypertonic saline-induced sputum on tbe one band and BW and BAL on tbe otber in patients witb astbma. In addition, tbere was a trend towards sucb a correlation between tbe absolute numbers of eosinopbils per mL sputum and per mm^ lamina propria in broncbial biopsy specimens. Finally, we bave sbown a correlation for 004"*" lympbocytes between sputum and BAL. Tbese findings indicate tbat eosinopbilic and lympbocytic inflammation in bypertonic saline-induced sputum modestly reflects sucb inflammation in tbe intrapulmonary airways. Tbis suggests tbat induced sputum, is a non-invasive alternative for broncboscopy in studying intraluminal airway inflammation in patients witb astbma.
Tbe inflammatory cell differentials in sputum, BW and BAL, and tbe flow cytometric data in sputum and BAL presented in tbis study seem to be in accordance witb tbose in otber studies [7, 15, 17, [28] [29] [30] . Comparison of tbe inflammatory infiltrate in broncbial biopsies between our and previous studies, bowever, reveals tbat we bave found relatively bigb inflammatory cell numbers in tbe lamina propria [4, 5, 31, 32] . A plausible explanation for tbis discrepancy migbt be our usage of 6 /xm cryostat sections [27] instead of 1 ixm plastic embedded sections [5, 31] , wbicb allows more cell layers to be counted.
Tbis is one of tbe first studies in atopic astbmatic subjects on tbe comparison of cell differentials between induced sputum and broncbial biopsies. We bave demonstrated a trend towards a relationsbip between eosinopbils numbers in sputum and £02"*" cells in broncbial biopsies in a group of astbmatic subjects irrespective of tbe treatment level. Tbis finding is in close agreement witb a recent study by Maestrelli et al. sbowing a non-significant trend towards a correlation between induced sputum and broncbial biopsies for eosinopbil counts in a group of astbmatics consisting of atopic, intrinsic and isocyanate allergic subjects [20] . Hence, induced sputum appears only to be a weak reflection of eosinopbilic inflammation in tbe broncbial walls of patients witb astbma.
Cell differentials obtained from sputum, BW and BAL bave been compared by several groups [16] [17] [18] [19] [20] . Tbe correlations for tbe percentage of eosinopbils between sputum and BW, and between sputum and BAL sbown bere, are confirming and extending earlier publisbed results [16, 18, 20] . We bave demonstrated tbat tbe correlations for eosinopbils exist in astbmatics covering a wide range in disease severity. In addition, we bave found a correlation between sputum and BAL for CD4~'' lympbocytes, and weak correlations for CD8'*' lympbocytes and tbe CD4/CD8 ratio, and between sputum and BW for lympbocytes. Tbese relationsbips migbt reacb significance wben tbe group would bave been enlarged. Our findings are not confirming tbose by Faby et al. [17] , wbo observed a closer resemblance between sputum and BW as compared to sputum and BAL in 10 astbmatic subjects. Particularly wben looking at CD4''" lympbocytes, as %CD4'' lymphocytes in sputum measured by flow cytometry, our data might be indicative of the reverse. This might be remarkable, since BAL fluid is considered to represent both the airway and alveolar compartments. However, we believe that the anatomical interpretation of these relationships has to await clarification of the sites of origin of inflammatory cells in induced sputum, which at present is still unknown. Since this study was designed to compare three methods to investigate airways inflammation, we tried to eliminate all sources of potential errors involved in subject selection, study design, the method of sputum induction and processing, the methodology of bronchoscopy, cell counting procedures and the statistical analysis. We have selected asthmatic subjects following strict inclusion criteria in order to exclude any other diseases than asthma. All participating subjects were atopie, non-smoking adults with hyperresponsiveness to inhaled methacholine and with reversible airways obstruction. This group of subjects had a wide range in lung function, airway hyperresponsiveness and anti-asthma medication usage and, thus, yielded a representative crosssection of an asthmatic population. We believe this wide range of asthma severity was needed in our study, because we aimed to investigate the relationship between inflammatory cell differentials in sputum, lavage fluid and bronchial biopsy specimens in patients in whom monitoring of sputum cells can potentially improve their clinical management.
Comparison of inflammatory cell counts in asthma 111
Induction of sputum by inhalation of aerosolized hypertonic saline is a frequently used method to obtain intrapulmonary epithelial lining fluid [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] 23, 28, 33] . The used 'whole sample' method has been shown to provide repeatable measurements of cellular, as well as soluble markers in both mild and severe asthmatic patients [23] . And even though the whole sample method results in variable salivary contamination, it enabled us to examine all cells in the obtained sample of airway lining fluid, and allowed storing of sputum supematants. Differential cell counts made on cytospin preparations of sputum were performed according to recommendations for differentiation of BAL, i.e. counting 500 inflammatory cells [34] . However, we included columnar epithelial cells in the cell differentials, since the amount of ciliated epithelial cells in BAL is inversely related to methacholine hyperresponsiveness and thereby possibly with disease severity [35, 36] . Differential cell counts were expressed as percentage of non-squamous cells, in order to be able to compare cell differentials between subjects with variable salivary contamination. The same standardization of inflammatory cell counts was used for BW and BAL cytospins, which justifies the comparison of cell differentials between sputum, BW and BAL.
Finally, it is usual to express inflammatory cells in induced sputum as percentage of total (non-squamous) cells. However, for comparison of inflammatory cell counts in sputum with those in bronchial biopsies, we chose to express inflammatory cells in induced sputum as number of cells/ mL sputum as opposed to percentage in sputum [20] , since it can be argued that it is not appropriate to correlate relative cell differentials in sputum with absolute cell counts in bronchial biopsies. Earlier studies on the comparison of inflammatory cells in BAL with those in bronchial biopsies have also used this method to analyse correlations [37] .
How can the present findings be interpreted? Transepithelial migration of inflammatory cells from the airway tissue into the lumen is a highly speciflc process, requiring multiple pathways of cellular adherence and activation [38, 39] . Therefore, in analogy with the comparison of inflammatory cells between BAL and biopsies [1, 30, 37, 39] , it is not unexpected that the leucocyte counts in sputum do not fully represent those in bronchial biopsies. In this view, it is quite remarkable that we did find a relationship between these two compartment for eosinophils. Apparently, transendothelial cell trafflc from blood into the airway tissue is often accompanied with transepithelial migration in asthma.
What are the clinical implications of this study? Assuming that inflammatory cell counts in bronchial biopsies can be considered as the present gold standard of measuring airway pathology in asthma [1] , our flndings indicate that induced sputum only modestly reflects mucosal inflammation in bronchial biopsies. However, induced sputum does seem to be a suitable, non-invasive technique providing a rough estimate of intraluminal inflammation in asthma. This suggests that cellular markers in induced sputum can be used in monitoring patients with asthma. However, such approach needs to be established in follow-up studies on the comparison of induced sputum with bronchial biopsies, BAL or BW in prospective, long-term trials, in well-deflned subgroups of patients with varying disease severity and different treatment levels.
